Literature DB >> 28802144

The effect of CYP2C19 genetic polymorphism and non-genetic factors on clopidogrel platelets inhibition in East Asian coronary artery disease patients.

Arwa M Amin1, Lim Sheau Chin2, Dzul Azri Mohamed Noor2, Hamza Mostafa2, Muhamad Ali S K Abdul Kader3, Yuen Kah Hay2, Baharudin Ibrahim2.   

Abstract

Entities:  

Keywords:  CYP2C19; Clopidogrel; Coronary artery disease patients; Dual antiplatelet therapy (DAPT); High on treatment platelets reactivity; VerifyNow

Mesh：

Substances：

Year:  2017        PMID： 28802144     DOI： 10.1016/j.thromres.2017.07.032

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Comparison between ticagrelor versus clopidogrel in long term outcomes of Taiwanese diabetic subjects with acute coronary syndrome undergoing successful revascularization: From TSOC ACS-DM registry.

Authors:  Cheng-An Wang; Yi-Chen Hsieh; Chun-Yao Huang; Ju-Chi Liu; Ming-Hsiung Hsieh; Yung-Kuo Lin; Jong-Shiuan Yeh
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

2.  Effects of different CYP2C19 genotypes on prognosis of patients complicated with atrial fibrillation taking clopidogrel after PCI.

Authors:  Qifeng Zhang; Zhixiong Zhong; Bin Li; Zhengxian Liao; Pingsen Zhao; Zhuolian Ye; Xuebo He; Hao Wang; Wenhao Chen; Junping Huang
Journal:  Exp Ther Med       Date:  2018-08-22       Impact factor: 2.447

Review 3.  The Role of Genetic Polymorphism and Other Factors on Clopidogrel Resistance (CR) in an Asian Population with Coronary Heart Disease (CHD).

Authors:  Mohammed Ahmed Akkaif; Nur Aizati Athirah Daud; Abubakar Sha'aban; Mei Li Ng; Muhamad Ali Sk Abdul Kader; Dzul Azri Mohamed Noor; Baharudin Ibrahim
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

4.  Cyp2C19*2 Polymorphism Related to Clopidogrel Resistance in Patients With Coronary Heart Disease, Especially in the Asian Population: A Systematic Review and Meta-Analysis.

Authors:  Ying Sun; Qing Lu; Xuefei Tao; Biao Cheng; Guoxing Yang
Journal:  Front Genet       Date:  2020-12-22       Impact factor: 4.599

5.  Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor.

Authors:  Hui Li; Hanjing Chen; Weili Chen; Hongrong Xu; Fei Yuan; Mengjie Yang; Hongbin Sun; Jin Yang; Yongqiang Liu; Xiaojuan Lai; Yanchun Gong; Xuefang Liu; Yongguo Li; Lei Sheng; Chao Liu; Xuening Li
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.